Skip to main content

Establishment profile

GENENTECH USA

CA, 94080
EIN 205958096

Download as PDF →

OSHA inspections
0
Violations
0
Penalties
$0
Context
No OSHA inspections on record. This does not mean the employer is violation-free — OSHA inspects a small fraction of workplaces annually.

Summary

GENENTECH USA has no OSHA inspection history on file. Federal records covering wage, environmental, labor relations, and other agencies are noted below where present.

The most recent federal enforcement activity was recorded 0 days ago.

Federal records were found in 2 of 15 sources. Sources without matching records returned empty for this establishment.

Agency coverage

GENENTECH USA appears in OFLC visa and labor certification and CPSC product recalls records only. No matching records were found in OSHA workplace safety, WHD wage enforcement, MSHA mine safety, EPA environmental compliance, NLRB labor relations, FMCSA motor carrier registration, SAM.gov federal debarment, CMS nursing home enforcement, UVA Corporate Prosecution Registry, or NHTSA vehicle recalls.

OSHA workplace safety

No OSHA inspections, citations, or accidents on file for GENENTECH USA. Verify directly with Occupational Safety and Health Administration

Safety self-report (OSHA 300A)

Recordable injury rates the employer filed with OSHA’s Injury Tracking Application. DART covers cases with days away, restricted, or transferred; TRIR is the total recordable case rate.

DART rate
0.4
vs industry
TRIR
1.7
vs industry

Reported for 263 average annual employees at this establishment.

Source: OSHA ITA Form 300A (employer self-reported). Rates are per 100 full-time equivalent workers. Establishments below the ~10-FTE threshold are not required to report.

OSHA severe injury reports

No severe injury reports (hospitalization, amputation, or loss of an eye) on file under 29 CFR 1904.39 for GENENTECH USA. Verify directly with Occupational Safety and Health Administration

Activity timeline

Data refreshed
Weekly
First OSHA inspection
Most recent activity
0 days ago

Most recent federal enforcement activity recorded 0 days ago. Data on this page is refreshed weekly.

Wage & Hour Division (WHD)

No WHD wage, overtime, or child-labor enforcement cases on file for GENENTECH USA. Verify directly with Wage and Hour Division

Mine safety (MSHA)

No MSHA mine safety violations on file for GENENTECH USA. Verify directly with Mine Safety and Health Administration

Labor relations (NLRB)

No NLRB unfair labor practice charges or union representation cases on file for GENENTECH USA. Verify directly with National Labor Relations Board

Visa & labor certification (OFLC)

Total applications
38
Certified
34
Avg wage ratio
1.12x
H-1B

Office of Foreign Labor Certification — labor condition applications for H-1B, H-2A, H-2B visa programs. Wage ratio = offered / prevailing wage.

Environmental compliance (EPA)

No EPA inspections or formal enforcement actions on file for GENENTECH USA. Verify directly with Environmental Protection Agency

Federal criminal prosecution record

No federal criminal prosecutions, plea agreements, or deferred-prosecution agreements on file for GENENTECH USA. Verify directly with UVA Corporate Prosecution Registry

CPSC product recalls

Total recalls
1
Last 5 years
0
Last 12 months
0
Units recalled
0

Top hazard: The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA).. Most recent recall: 2021-03-18. Source: Consumer Product Safety Commission, matched on company name.

Federal contracts

This location

Obligated (5-yr)
$167.1M
Obligated (all-time)
$225.1M
Awards
506
Top agency
Department of Health and Human Services
$166.5M
Company-wide — ROCHE HOLDING AG (across 6 entities)
Obligated (5-yr)
$343.0M
Obligated (all-time)
$352.3M
Awards (all-time)
787

Consolidated across all USAspending recipient entities under this corporate parent — not attributable to this single location.

Top agencies by obligation (this location)
Department of Health and Human Services$166.5M
Department of Defense$57.1M
Department of Justice$949K
Department of Homeland Security$358K
Department of Agriculture$194K
Largest awards (top 50 of 506)
  • Department of Health and Human Services
    THE PURPOSE AND NEED FOR THIS PROPOSED REQUIREMENT IS TO PROVIDE THE DIVISION OF STRATEGIC NATIONAL STOCKPILE (DSNS), ASSISTANT SECRETARY OF PREPAREDNESS AND RESPONSE (ASPR), WITH A CONTRACTING VEHICLE FOR PRODUCT(S) NEEDED IN ORDER TO SUPPORT "
    contract · Last action 2024-11-25
    $60,000,000
  • Department of Health and Human Services
    OSELTAMIVIR PHOSPHATE (TAMIFLU) 30MG AND 75MG CAPSULES
    contract · Last action 2026-03-27
    $45,106,864
  • Department of Health and Human Services
    PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS
    contract · Last action 2026-03-17
    $37,485,000
  • Department of Health and Human Services
    XOFLUZA (BALOXAVIR MARBOXIL)
    contract · Last action 2024-09-27
    $21,999,907
  • Department of Defense
    8503701116!OSELTAMIVIR PHOSPHA
    contract · Last action 2016-09-28
    $9,862,682
  • Department of Defense
    8503667680!OSELTAMIVIR PHOSPHA
    contract · Last action 2016-09-20
    $8,434,278
  • Department of Defense
    8503667563!OSELTAMIVIR PHOSPHA
    contract · Last action 2016-09-20
    $6,993,124
  • Department of Defense
    8506792044!OSELTAMIVIR PHOSPHA
    contract · Last action 2020-11-04
    $4,343,442
  • Department of Defense
    8505903119!OSELTAMIVIR PHOSPHA
    contract · Last action 2018-09-21
    $3,098,165
  • Department of Health and Human Services
    OPHPR PURCHASE OF TAMIFLU SUSPENSION
    contract · Last action 2016-06-27
    $1,909,809
  • Department of Defense
    8505903299!OSELTAMIVIR PHOSPHA
    contract · Last action 2018-09-24
    $1,718,297
  • Department of Defense
    8504742896!OSELTAMIVIR PHOSPHA
    contract · Last action 2017-09-12
    $1,555,072
  • Department of Defense
    8503667374!OSELTAMIVIR PHOSPHA
    contract · Last action 2016-09-20
    $1,185,183
  • Department of Defense
    8504743044!OSELTAMIVIR PHOSPHA
    contract · Last action 2017-09-12
    $992,672
  • Department of Defense
    8511378265!OTHER MEDICAL
    contract · Last action 2025-05-14
    $872,421
  • Department of Defense
    8507376885!OTHER MEDICAL
    contract · Last action 2020-05-15
    $690,616
  • Department of Defense
    8507096058!OTHER MEDICAL
    contract · Last action 2023-07-18
    $648,415
  • Department of Defense
    8508214020!OTHER MEDICAL
    contract · Last action 2021-06-22
    $562,174
  • Department of Defense
    8510632021!OTHER MEDICAL
    contract · Last action 2024-05-15
    $543,592
  • Department of Defense
    8509885034!OTHER MEDICAL
    contract · Last action 2024-12-06
    $541,821
  • Department of Defense
    8505903112!OSELTAMIVIR PHOSPHA
    contract · Last action 2018-09-21
    $468,558
  • Department of Defense
    !
    contract · Last action 2015-05-13
    $414,642
  • Department of Defense
    8505504092!OTHER MEDICAL
    contract · Last action 2018-05-16
    $396,160
  • Department of Defense
    MEAT, POULTRY, AND FISH
    contract · Last action 2014-05-19
    $376,817
  • Department of Defense
    8504743583!OSELTAMIVIR PHOSPHA
    contract · Last action 2017-09-13
    $364,101
  • Department of Homeland Security
    PROCUREMENT OF TAMIFLU
    contract · Last action 2014-03-26
    $355,940
  • Department of Defense
    8503685863!0SELTAMVIR PHOSPHA
    contract · Last action 2016-10-20
    $353,101
  • Department of Defense
    !
    contract · Last action 2017-05-03
    $343,886
  • Department of Defense
    8506792043!OSELTAMIVIR PHOSPHA
    contract · Last action 2020-11-04
    $342,871
  • Department of Justice
    MEDICATION
    contract · Last action 2014-07-03
    $288,600
  • Department of Defense
    !
    contract · Last action 2016-05-04
    $263,722
  • Department of Defense
    8503667826!OSELTAMIVIR PHOSPHA
    contract · Last action 2016-09-20
    $259,393
  • Department of Defense
    8509110403!OTHER MEDICAL
    contract · Last action 2022-05-18
    $254,736
  • Department of Defense
    8506792045!OSELTAMIVIR PHOSPHA
    contract · Last action 2020-11-04
    $243,163
  • Department of Defense
    8505903708!OSELTAMIVIR PHOSPHA
    contract · Last action 2018-09-24
    $228,799
  • Department of Defense
    8504738073!OSELTAMIVIR PHOSPHA
    contract · Last action 2017-09-11
    $228,799
  • Department of Agriculture
    IGF::OT::IGF TAMIFLU (OSELTAMIVIR PHOSPHATE) CAPSULES, 75 MG
    contract · Last action 2016-05-10
    $193,939
  • Department of Defense
    8505903295!OSELTAMIVIR PHOSPHA
    contract · Last action 2018-09-21
    $179,993
  • Department of Defense
    8504743494!OSELTAMIVIR PHOSPHA
    contract · Last action 2017-09-12
    $179,993
  • Department of Defense
    8504733580!OSELTAMIVIR PHOSPHA
    contract · Last action 2017-09-08
    $172,416
  • Department of Defense
    8505904700!OSELTAMIVIR PHOSPHA
    contract · Last action 2018-09-24
    $172,397
  • Department of Defense
    8503680082!OSELTAMIVIR PHOSPHA
    contract · Last action 2016-09-22
    $172,070
  • Department of Defense
    8505903706!OSELTAMIVIR PHOSPHA
    contract · Last action 2018-09-24
    $159,763
  • Department of Defense
    8504738405!OSELTAMIVIR PHOSPHA
    contract · Last action 2017-09-11
    $159,763
  • Department of Defense
    8504733691!OSELTAMIVIR PHOSPHA
    contract · Last action 2017-09-08
    $150,744
  • Department of Defense
    8505904477!OSELTAMIVIR PHOSPHA
    contract · Last action 2018-09-24
    $150,725
  • Department of Defense
    8503680002!OSELTAMIVIR PHOSPHA
    contract · Last action 2016-09-26
    $149,340
  • Department of Defense
    8503673498!OSELTAMIVIR PHOSPHA
    contract · Last action 2016-09-21
    $149,340
  • Department of Defense
    8503669174!OSELTAMIVIR PHOSPHA
    contract · Last action 2016-09-20
    $143,456
  • Department of Defense
    8503685571!OSELTAMIVIR PHOSPHA
    contract · Last action 2016-09-23
    $141,052

Federal contract dollars to this establishment. Primary NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURING. Last action: 2026-03-31. Source: USAspending.gov, net obligations. Recipient address is the SAM registration / HQ address, not necessarily the worksite.

In the news

Related searches

Need API access, bulk download, or licensed redistribution? The website is free. Programmatic and licensed access is handled separately.

Contact sales →

About this data

This profile aggregates federal enforcement records on GENENTECH USA from every major federal compliance and enforcement source plus the UVA Corporate Prosecution Registry. OSHA workplace safety inspections, WHD wage cases, MSHA mine safety, EPA environmental enforcement, NLRB labor relations, OFLC visa/labor certification, FMCSA motor carrier registration, SAM.gov debarments, CMS nursing-home records, BLS industry safety benchmarks, OSHA ITA self-reported injury rates, SEC enforcement and financial disclosures, CPSC and NHTSA recalls.

Establishments are matched across agencies using normalized employer name, state, and ZIP code.

OSHA citations typically appear 3–8 months after the inspection, so very recent enforcement actions may not yet be reflected. Profiles may be incomplete if the establishment operates under multiple legal names or files under variations our entity-matching rules don’t yet cover. To report a missing record or correction, email corrections@fastdol.com.

Frequently asked

What is GENENTECH USA's OSHA violation history?
GENENTECH USA has no OSHA inspections on record.